Schedule 13G ownership disclosure

IMPRIMIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 45323A201

Event date: 2015-05-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-15-002169
Form type
SC 13G/A
Filer
HARROW, INC.
CIK
CIK 1360214
Filed
May 20, 2015
Reporting period
May 18, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub